Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor immune-profiling assay requiring only two FFPE...
Read More »Cofactor Genomics Announces $18M Funding Round to Bring RNA to Precision Medicine
Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing ...
Read More »Cofactor Genomics Launches Pinnacle – a CAP-CLIA Certified RNA-Based Oncology Assay
Cofactor Genomics, a software-driven biotechnology company developing unique molecular diagnostics centered on RNA, has launched a clinically-validated oncology assay which provides unique insight into a patient’s cancer profile. The assay, named Cofactor Pinnacle, utilizes the company’s proprietary software technology to ...
Read More »A Method for Surveying the Long-RNA Landscape of Exosomes
The emergence of next-generation sequencing platforms has enabled the discovery and interrogation of RNA from tissues, biofluids, and extracellular vesicles at remarkable levels. Recently, interest has grown in sequencing RNA found in extracellular vesicles called exosomes, because of their role ...
Read More »Maverix Biomics Offers Free Trial of Self-Service RNA-Seq Data Analysis
SAN MATEO – Mar 1, 2016 – Maverix Biomics, a leading Next Generation Sequencing (NGS) data analysis software company, today made available a free 30-day trial of the Maverix WAVES RNA-Seq Gene Expression Analysis solution. (www.maverixbio.com/registration/registration.html) Before today, scientists conducting ...
Read More »Medical Testing Is So Hot Right Now. This Startup Wants In
from Wired.com by Nick Stockton The California headquarters of Cofactor Genomics is a bright little bungalow a few blocks from downtown Mountain View. Floral vines abuzz with insects and hummingbirds partially obscure the patio and its two Adirondack chairs. Jarret ...
Read More »Cofactor Genomics Earns Phase II Award from NIH for Further Development of Circular RNA Enrichment Technology
Cofactor Genomics has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. This award follows a successful phase I showing the performance ...
Read More »Cofactor Genomics Awarded NIH Grant to Develop a Circular RNA Enrichment Kit and Reference Profile
August 2014, Cofactor Genomics has been awarded a grant by the National Institute of Mental Health (NIMH), an institute of the NIH, to develop a standardized enrichment kit and define the normal reference profile for circular RNAs (circRNA) in the nervous ...
Read More »6 Changes That’ll Make a Big Difference With Your RNA-seq
from Cofactor Genomics 1. Sample Quality and and stringent QC measures First and foremost, if a sample is of low quality or complexity, both of which can occur due to degradation, then it is best to either not sequence or ...
Read More »Cofactor Genomics – RNA-seq: Trust Your Results. Driving Confidence by Characterizing Variability
Plant & Animal Genome XXII – Industry Workshop RNA-seq has proven to be an invaluable tool for researchers across multiple disciplines. While allowing novel understanding of expression, there are limitations to the technology’s controls, measures of confidence, and methods of ...
Read More »